Host immune responses to mycobacterial antigens and their implications for the development of a vaccine to control tuberculosis
Clinical and Experimental Vaccine Research · 2014 · 3 (2) · 155
DOI: 10.7774/cevr.2014.3.2.155 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical and Experimental Vaccine Research, 2014. Verfasst von Jae-Min Yuk und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Infection Signaling Network Research Center, Chungnam National University School of Medicine, Daejeon, Korea. Die Arbeit wurde bisher 45-mal zitiert (Crossref) und nennt 134 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Microbiology and Infection Signaling Network Research Center, Chungnam National University School of Medicine, Daejeon, Korea.
ORCID-Profile: Jae-Min Yuk, Eun-Kyeong Jo
Förderung
- National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP)
Zitieren
APA
Yuk, J. M., & Jo, E. K. (2014). Host immune responses to mycobacterial antigens and their implications for the development of a vaccine to control tuberculosis. Clinical and Experimental Vaccine Research, 3(2), 155. https://doi.org/10.7774/cevr.2014.3.2.155
Vancouver
Yuk JM, Jo EK. Host immune responses to mycobacterial antigens and their implications for the development of a vaccine to control tuberculosis. Clinical and Experimental Vaccine Research. 2014;3(2):155. doi:10.7774/cevr.2014.3.2.155
BibTeX
@article{Yuk2014,
author = {Yuk, Jae-Min and Jo, Eun-Kyeong},
title = {Host immune responses to mycobacterial antigens and their implications for the development of a vaccine to control tuberculosis},
journal = {Clinical and Experimental Vaccine Research},
year = {2014},
volume = {3},
number = {2},
pages = {155},
doi = {10.7774/cevr.2014.3.2.155}
}
EUVIMED